Jim Cramer Says Wait Before Buying the Dip on Vertiv: “You’ll Get A Better Price.”

Photo of Thomas Richmond
By Thomas Richmond Published

Quick Read

  • Cramer diagnosed VRT and MCHP selloffs as margin-driven forced selling, not fundamental deterioration, and told buyers to wait for a better entry price.

  • Vertiv's Q1 beat consensus EPS by 16 cents, grew revenue 30%, and holds a $15B backlog up 109% year over year, supporting the fundamentals-intact case.

  • Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and Microchip Technology didn't make the cut. Grab the names FREE today.

Jim Cramer Says Wait Before Buying the Dip on Vertiv: “You’ll Get A Better Price.”

© 24/7 Wall St.

On a recent Mad Money segment, a caller who identified herself as Sunshine from Florida asked Jim Cramer about Vertiv (NYSE:VRT | VRT Price Prediction). Her framing: Vertiv took a bigger hit today than my air conditioner does in a Florida summer. The stock is down 11.88% in the past month, and she was wondering whether she should buy the dip.

Jim Cramer’s answer was to wait. He acknowledged that Vertiv’s fundamentals remained intact, but sellers might still have more to unload.

“You’ll Get a Better Price”: Why Cramer Says to Wait Before Buying the Dip

Cramer’s read on the tape: Vertiv is in speculative hands right now. The speculative hands are being margined out.” His follow-up was equally direct: “They’re going to get rid of them, and you’ll get a better price if you want to buy. On timing, he suggested the bottom was close but not in, telling the caller, “We’re not far from it, but we’re not there yet.”

Vertiv opened the week on July 20, 2026, at $289.56, a 9.19% decline over the prior five sessions and roughly 8.82% below its June 17 level. Year to date, the stock is still up 78.81%, and one-year performance sits at 121.07%. The stock’s pullback after a parabolic run might be causing levered longs to sell into weakness regardless of the story.

Vertiv’s Business Is Booming Even as the Stock Drops

Vertiv’s most recent numbers look strong. First-quarter 2026 results, reported April 22, 2026, delivered adjusted diluted EPS of $1.17 against a $1.01 consensus on revenue of $2.649 billion, up 30.1% year over year. Adjusted operating margin expanded 430 basis points to 20.8%, and operating cash flow soared 152.82%. Management raised full-year 2026 guidance to $13.50B to $14.00B in net sales and $6.30 to $6.40 in adjusted EPS. Americas revenue was $1.814 billion at 53.1% growth, offset by EMEA down 20.3%.

The Q4 2025 backlog stood at $15.0 billion, up 109% year over year, with a book-to-bill near 2.9x. Vertiv was added to the S&P 500 in March 2026 and picked up inaugural investment-grade ratings from Moody’s (Baa3) and S&P (BBB-). CEO Giordano Albertazzi framed the setup: “As infrastructure density increases and deployment timelines compress, we’re positioned to be the partner customers need to bring their most ambitious projects to life, at scale.

VRT earnings explorer

Cramer Sees the Same Forced Selling Hammering Microchip

Cramer extended the same “wait out the forced sellers” diagnosis in the segment to Microchip Technology (NASDAQ:MCHP), arguing margin unwinds were distorting prices across semis and data center infrastructure names alike.

Microchip opened July 20 at $80.96, down 8.61% on the week and 13.97% over one month, even as the operational turnaround under CEO Steve Sanghi keeps producing. Q4 fiscal 2026 revenue was $1.311 billion, up 35.1% year over year; non-GAAP EPS came in at $0.57, and June-quarter guidance calls for $1.442 billion to $1.469 billion in sales with distributor inventory now at 26 days.

What to Watch Next

Cramer’s message is simple: Vertiv’s decline may reflect forced selling rather than weakness in the underlying business. The company reports Q2 earnings next, with guidance calling for $3.25 billion to $3.45 billion in sales and adjusted EPS of $1.37 to $1.43. Investors should watch whether the selling pressure fades and whether Vertiv reports improving conditions in Europe, the Middle East, and Africa.

Contact [email protected] for any questions or corrections.

Photo of Thomas Richmond
About the Author Thomas Richmond →

Thomas Richmond is a financial writer and content strategist with 5+ years of experience covering stocks and financial markets. He has published over 250 articles focused on individual stock analysis, helping investors better understand business fundamentals, stock valuations, and long-term opportunities.

Thomas previously served as a Content Lead at TIKR, a stock research platform, where he helped scale the company’s blog to hundreds of articles per month and contributed to a weekly newsletter reaching more than 100,000 investors.

He specializes in breaking down complex companies into clear, actionable insights for everyday investors, with a focus on fundamentals-driven research.

His work has also been featured on platforms including Seeking Alpha and Sure Dividend.

Outside of work, Thomas enjoys weight lifting and soccer.

Continue Reading

Top Gaining Stocks

GPN Vol: 5,888,970
TER Vol: 2,940,439
AXON Vol: 828,725
DASH Vol: 2,831,716
LYB Vol: 5,327,300

Top Losing Stocks

CTRA Vol: 73,319,495
ENPH Vol: 3,986,110
ORCL Vol: 36,791,047
KKR
KKR Vol: 3,398,273
UPS Vol: 7,648,289